Skip to content
★ Sign in to follow
KK

Kevin Krenitsky

CEO
CapForce Inc.Enzo Biochem IncFoundation Medicine, Inc.
Total declarations
10
Companies
3
▲ Purchases (3 ops.)
€79k
▼ Sales (2 ops.)
€2,412

Latest filing published 23 May 2016 for CapForce Inc..

Insider track record

Disclosed buys
3
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
3

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 12 May 2015 · 4199 days ago · €44k
    -70.8%
    Entry US$390,000.00 · Close at T+365 US$114,000.00

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Kevin Krenitsky: trading record in brief

Kevin Krenitsky discloses dealings in 3 companies, chiefly Foundation Medicine, Inc., CapForce Inc. and Enzo Biochem Inc. Over a trading history stretching from 15 October 2009 to 19 May 2016, the count stands at 10 filings.

On the open market, the record shows 3 purchases worth €79k and 2 sales worth €2,412. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. So far in 2016, the count stands at 1 purchase and no sales.

The newest entry dates from 23 May 2016: an open-market purchase, in CapForce Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kevin Krenitsky

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total

9 of 9 declarations